BetterHelp
Largest therapist network with flexible scheduling.
Messaging included between live sessions.
Weekly billing applies whether or not you meet.
Largest therapist network with flexible scheduling.
Messaging included between live sessions.
Weekly billing applies whether or not you meet.
Defined plans with clear session allowances.
Psychiatry and prescribing available on higher tiers.
Insurance acceptance is broader than most rivals.
Reduced-rate sessions with licensed clinicians.
One-time membership fee rather than a subscription.
Smaller network, longer waits in some areas.
Built around psychiatry and medication management.
Therapy available alongside prescribing.
Has faced regulatory scrutiny over prescribing practices.
Video visits through an established telehealth platform.
Strong insurance integration.
Less therapy-specific tooling than dedicated platforms.
That is not a criticism of messaging-based care, which has real evidence behind it for some concerns. It is a criticism of comparing an asynchronous plan to a live-session plan as if they were the same purchase.
Therapy is regulated at the state level. A clinician must be licensed where the client is physically located, which creates a real operational problem for national platforms and a real risk for clients who never think to ask. The platforms that score well here display license type and state, and can explain how they match clients to clinicians authorized to treat them.
Most platforms are designed for ongoing, sub-acute care. That is a legitimate scope. The problem is when the marketing implies more. A platform should state plainly that it is not an emergency service, describe its risk-screening process, and route people to crisis resources without friction.
In the US, 988 is the Suicide and Crisis Lifeline, available by call or text. Any platform that does not surface something equivalent is telling you what it thinks about scope.
Weekly billing regardless of attendance, automatic renewal, and cancellation windows that sit just past the point you would naturally notice are the recurring complaints in this category. None of this is unique to online therapy, but the population using it is often in a worse position to fight a billing dispute.
We do not evaluate clinical outcomes and we do not provide therapy. We score what is checkable from outside: whether licensing is disclosed, whether a crisis protocol is described, whether scope limits are stated, how transparent pricing and cancellation are, and what the privacy policy commits to on therapy records.
The scores below compare platforms against the same safety and transparency topics. A high score means the platform documents its licensing, scope and crisis handling more clearly. It does not mean the platform is right for your situation, and it is not a clinical recommendation.
This measures whether the platform states plainly what it treats, what it does not, and whether it is an emergency service. It matters because the gap between ongoing talk therapy and acute crisis care is where harm occurs.
Adapted here to mean access to a qualified clinician: whether the platform discloses therapist credentials, license type and state, and whether you can see who you are being matched with before committing.
Adapted here to mean consent and record clarity: what you agree to at signup, whether sessions are recorded, who can access notes, and what happens to your records if you cancel.
Adapted here to mean clinical credentialing: whether the platform verifies licenses, how it handles clinicians practicing across state lines, and whether credentials can be checked independently.
This measures whether claims about effectiveness, therapist quality and matching are specific and checkable rather than aspirational. It matters because this category markets heavily on emotional outcomes.
Adapted here to mean therapist match quality: network size, whether you can switch at no cost, and how matching actually works beyond a questionnaire.
Adapted here to mean methodology transparency: whether the platform explains its matching logic, its clinical model, and the evidence base for the modality it sells.
This measures what the policy commits to on therapy records, retention periods and deletion requests. It matters because therapy notes are among the most sensitive records a person generates.
This measures ownership history and how the company has handled past regulatory or billing scrutiny. It matters because a therapy relationship depends on continuity and on data governance that survives a change of control.
This measures whether session data or intake data can be used for research or shared with third parties, and whether that is opt-in. It matters because intake questionnaires collect a great deal of information before any therapy begins.
BetterHelp's advantage is logistical: the largest network means a better chance of a workable match and a faster swap when the first one is not right. Messaging between sessions fills the gaps that weekly video leaves. The trade-offs are real: billing is weekly regardless of attendance, and the platform has drawn regulatory attention over its marketing and data practices in the past, which is priced into the evidence score here.
Adults seeking ongoing talk therapy with flexible scheduling and between-session contact.
Anyone in acute crisis, or anyone who needs a specific modality or a psychiatrist.
Scope is stated but frequently missed by users, which is the risk. Therapy records are sensitive and retention follows account policy; cancellation does not automatically delete clinical notes.
Talkspace sells defined plans rather than open-ended access, which makes it easier to know what you are buying: a set number of live sessions plus messaging, at a stated price. Psychiatry and prescribing are available on higher tiers, which matters for anyone whose care includes medication. Insurance coverage is broader than most of the category, which changes the real cost for a lot of people.
People who want a defined plan and possibly medication management under one roof.
Anyone needing frequent between-session contact, or acute crisis care.
Scope is comparatively well stated, including what the platform does not treat. Records follow clinical retention rules, which is appropriate but worth understanding before you start.
Open Path exists to solve the cost problem rather than to scale a subscription. You pay a one-time membership fee, then book sessions at reduced rates directly with licensed clinicians who have agreed to offer them. There is no weekly billing and no automatic renewal, which removes the single most common complaint in this category. The cost is network size: availability varies by location and specialty.
People for whom subscription pricing is the barrier to licensed care.
Anyone needing between-session messaging or medication management.
The financial model is the differentiator and it also improves the privacy picture: less platform intermediation, fewer data touchpoints. Records sit with the clinician rather than a subscription account.
Cerebral is a psychiatry-first service where therapy is one component of a broader offer. For someone whose care involves medication, having prescribers and therapists in one system is genuinely convenient. The caution is historical: the company has faced regulatory scrutiny over prescribing practices, and the evidence score reflects that record rather than the current clinical staff.
Adults whose care plan includes medication and who want therapy alongside it.
Anyone seeking therapy alone, or anyone uncomfortable with a psychiatry-first model.
Scope is broad but the regulatory history is the material caveat. Data practices are documented, though the platform's record invites reading the terms closely.
Amwell is a general telehealth platform where therapy is one service among many. That structure is an advantage if you want care integrated with a broader medical relationship and covered by insurance, and a disadvantage if you want the therapy-specific tooling, matching and between-session messaging that dedicated platforms build around.
People who want therapy as part of a broader telehealth relationship.
Anyone wanting a therapy-first product with matching and messaging.
Clinical infrastructure is solid and records follow healthcare norms. The trade-off is that therapy-specific transparency, such as how matching works, is thinner than on dedicated platforms.